These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1122 related articles for article (PubMed ID: 25925492)
1. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492 [TBL] [Abstract][Full Text] [Related]
2. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116 [TBL] [Abstract][Full Text] [Related]
5. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842 [TBL] [Abstract][Full Text] [Related]
6. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398 [TBL] [Abstract][Full Text] [Related]
7. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma. Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196 [TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma. Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034 [TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663 [TBL] [Abstract][Full Text] [Related]
10. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline. Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511 [TBL] [Abstract][Full Text] [Related]
11. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487 [TBL] [Abstract][Full Text] [Related]
12. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547 [TBL] [Abstract][Full Text] [Related]
13. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
14. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma. Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894 [TBL] [Abstract][Full Text] [Related]
15. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data. Wang Y; Jiang Y; Chen L J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676 [TBL] [Abstract][Full Text] [Related]
16. Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma. Seki M; Sano T; Yokoo S; Oyama T Histopathology; 2017 May; 70(6):869-879. PubMed ID: 27926795 [TBL] [Abstract][Full Text] [Related]
17. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794 [TBL] [Abstract][Full Text] [Related]
18. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients. Velmurugan BK; Yeh KT; Lee CH; Lin SH; Chin MC; Chiang SL; Wang ZH; Hua CH; Tsai MH; Chang JG; Ko YC Oncotarget; 2016 Mar; 7(10):10879-90. PubMed ID: 26918356 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity. Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]